Wondering if NAD+ is right for you? Take the 3-min clinical quiz.
See if you qualify →The “Wolverine stack” is a nickname for combining two experimental peptides, BPC-157 and TB-500, usually marketed for injury recovery, inflammation, and tissue repair. Evidence in humans is very limited, neither peptide is FDA-approved for medical use, and dosing or safety standards are not well established.
What is the Wolverine stack?
The Wolverine stack usually means BPC-157 plus TB-500, two synthetic peptides promoted online for tissue repair. The name comes from the comic-book character known for fast healing, but the science is far less certain than the nickname suggests.
BPC-157 stands for Body Protection Compound-157, also called pentadecapeptide BPC-157. TB-500 is marketed as a synthetic peptide related to thymosin beta-4, a naturally occurring protein involved in cell movement and wound biology. Thymosin beta-4 has been studied in wound and corneal-healing models, but that does not prove that TB-500 injections repair human tendon, ligament, muscle, or joint injuries 3, 4.
The phrase Wolverine stack is not a medical diagnosis, an FDA-approved product name, or a standard treatment protocol. It is a marketing term used in peptide therapy discussions, often without the kind of human trial data clinicians rely on.
What are BPC-157 and TB-500?
BPC-157 and TB-500 are synthetic peptides, meaning short chains of amino acids made to mimic or modify biological signals. They are grouped together because both are discussed in tissue-repair research, but they are not the same compound and should not be treated as interchangeable.
| Peptide | What it is | Main research themes | Human evidence for injury recovery | Key safety unknowns |
|---|---|---|---|---|
| BPC-157 | A synthetic 15-amino-acid peptide, also called Body Protection Compound-157 or pentadecapeptide BPC-157 | Angiogenesis, collagen signaling, tendon and gut-injury models, inflammation pathways | Very limited; most support comes from animal and lab studies | Long-term safety, cancer-related signaling concerns, product quality, dosing standards |
| TB-500 | A marketed synthetic peptide commonly linked to thymosin beta-4 biology | Cell migration, actin binding, wound repair, blood-vessel growth, inflammation signaling | Limited for TB-500 specifically; thymosin beta-4 has early human and preclinical wound-healing research | Long-term safety, immune effects, injection risk, sport eligibility, product quality |
| Wolverine stack | A non-standard combination of BPC-157 and TB-500 | Anecdotal use for tendon injury, ligament injury, muscle strain, joint pain, chronic pain, and post-surgical recovery | No large FDA-reviewed trials proving benefit for these uses | Unknown combined-risk profile and no approved dosing schedule |
Why these peptides are combined
The theory is that BPC-157 may influence blood-vessel growth, collagen synthesis, and inflammatory signaling, while TB-500-related thymosin beta-4 pathways may support cell migration and wound remodeling 3, 4, 5, 6. In plain English: one is often framed around “repair signaling,” and the other around “cell movement and remodeling.”
That theory is biologically interesting, but it is not proof. Combination use raises a bigger evidence gap because the pair has not been tested in large, well-controlled human trials for injury recovery, post-surgical recovery, joint pain, or chronic pain.
Do Wolverine stack peptides actually work?
Human proof is the weak point. BPC-157 has shown effects in animal models of tendon, ligament, muscle, gut, and nerve injury, but animal findings often fail to translate into safe, effective human treatments 5, 6.
For thymosin beta-4 biology, early studies have explored wound healing, corneal repair, and tissue remodeling. For example, thymosin beta-4 has been studied for corneal epithelial wound healing and dermal wound repair, with mechanisms tied to cell migration and inflammation control 3, 4. These studies are not the same as proving that TB-500 repairs a torn tendon or speeds return to sport.
The important number is zero large FDA-approved indications for the Wolverine stack. Neither BPC-157 nor TB-500 has an FDA-approved medical use, and no FDA label gives a standard dosing schedule, injection frequency, cycling plan, or expected timeline.
Why anecdotes are not the same as clinical evidence
Anecdotes can feel convincing because pain and function naturally change over time. Rest, physical therapy, anti-inflammatory care, surgery, sleep, nutrition, and placebo effects can all overlap with peptide use.
Good clinical trials try to separate the treatment effect from normal healing. For the Wolverine stack, that kind of human evidence is not strong enough to support clear claims about tendon injury, ligament injury, muscle strain, joint pain, chronic pain, or post-surgical recovery.
What is the Wolverine stack used for?
Online use claims often focus on injury recovery, tendon pain, ligament sprain, muscle strain, joint pain, chronic pain, and post-surgical recovery. These are marketed uses, not FDA-approved indications.
- Tendon injury: BPC-157 has been investigated in animal tendon-healing models, but human tendon-repair benefits are not established 5.
- Ligament injury: animal studies suggest possible repair signaling, but there is no approved ligament-healing indication for BPC-157 or TB-500 6.
- Muscle strain: repair pathways are biologically plausible, but high-quality human evidence is limited.
- Joint pain or chronic pain: pain can come from many causes, so medical evaluation matters before trying any unapproved peptide.
- Post-surgical recovery: surgery recovery should be managed by the surgical team; peptides should not replace wound checks, rehab, infection monitoring, or follow-up care.
Gut-health claims tied to BPC-157
BPC-157 is also discussed for gut-health claims because it was first studied in gastric and intestinal injury models. Animal studies have explored effects in ulcer, fistula, and inflammatory injury models, but that is not the same as an FDA-approved treatment for human gut disease 7.
If you have ongoing abdominal pain, bleeding, weight loss, fever, severe reflux, inflammatory bowel disease, or new bowel changes, do not self-treat with research peptides. Those symptoms need clinician evaluation.
How are Wolverine stack peptides usually taken?
There is no FDA-approved dosing schedule for BPC-157, TB-500, or the Wolverine stack. Because these compounds are not FDA-approved for medical use, there is no FDA label that defines dose, injection frequency, duration, cycling, storage, or monitoring.
Online forums often discuss subcutaneous injection, local injection near an injury, oral BPC-157, or nasal products. We do not recommend following those protocols. Injection technique, sterility, dose accuracy, drug interactions, and diagnosis all matter, and anonymous online instructions cannot account for them.
A major safety issue is sourcing. Peptides purchased online or labeled “for research use only” may be contaminated, mislabeled, under-dosed, over-dosed, or unsafe for human use. The FDA has warned consumers about risks from unapproved products and products marketed outside approved pathways 8.
Why there is no FDA-approved dosing schedule
A dosing schedule usually comes from clinical trials, FDA review, manufacturing controls, and a drug label. The Wolverine stack has not gone through that process. That means a clinician cannot point to an FDA-reviewed label for safety monitoring or dose adjustment.
How long does the Wolverine stack take to work?
There is no reliable timeline for the Wolverine stack because proven human benefits have not been established. Any online claim that it works in a set number of days or weeks should be treated as marketing unless it is tied to a specific, peer-reviewed human trial.
Injury recovery depends on the tissue involved, the severity of injury, blood supply, age, nutrition, sleep, rehab, and whether surgery is needed. Tendons and ligaments often heal slowly because their blood supply is limited, and trying to “speed up” recovery without a correct diagnosis can make the injury worse.
When to seek medical care instead of waiting
Seek medical care promptly for severe pain, a pop or tearing feeling, major swelling, inability to bear weight, weakness, numbness, fever, spreading redness, wound drainage, chest pain, shortness of breath, or pain after surgery. These can signal problems that peptides cannot safely diagnose or manage.
What are the risks and side effects of BPC-157 and TB-500?
The main risks are unknown long-term safety, injection-site reaction, infection risk, product-quality problems, and delayed care for a real injury. Because BPC-157 and TB-500 do not have FDA-approved labels, there is no FDA-reviewed list of common side effects, contraindications, or drug interactions.
- Injection-site reaction: redness, pain, bruising, swelling, or irritation can happen with injected substances.
- Infection risk: any injection can introduce bacteria if the product, needle, skin prep, or technique is not sterile.
- Allergic or immune reaction: rash, itching, swelling, or breathing symptoms need urgent medical attention.
- Theoretical growth-signal concerns: pathways such as angiogenesis and cell migration are useful in healing, but abnormal growth signaling is also why long-term safety needs study.
- Missed diagnosis: pain from fracture, tendon rupture, infection, inflammatory arthritis, or nerve injury can worsen if care is delayed.
This benefit-risk balance is the reason we separate evidence from marketing. A peptide can have an interesting mechanism and still lack enough human data to support self-use.
Drug testing and sport eligibility concerns
Competitive athletes should be especially careful. The World Anti-Doping Agency lists many non-approved substances and certain peptide classes as prohibited, and BPC-157 appears on WADA’s prohibited list 9. Sport rules can apply even if a product was bought online or labeled for research.
Is the Wolverine stack legal or FDA approved?
No FDA approval exists for the Wolverine stack, BPC-157, or TB-500 as medical treatments. In July 2026, the FDA’s Pharmacy Compounding Advisory Committee recommended BPC-157 and TB-500 for inclusion on the 503A Bulks List, but the committee vote is advisory and the FDA’s final determination is pending 1, 2.
The practical point is simple: a PCAC recommendation is not the same as FDA approval, and it does not create an FDA-approved Wolverine stack. Until the FDA acts, the day-to-day compounding status is unchanged from before the vote.
WADA and competitive-sport restrictions
Sport rules are separate from FDA rules. A product can be unapproved for medical use and also prohibited in sport. Athletes should check their governing body, team physician, and WADA rules before using any peptide 9.
How does the Wolverine stack compare with Chia’s longevity peptide options?
Chia does not currently offer BPC-157, TB-500, or a Wolverine stack. We do offer other longevity-focused treatments through an online visit reviewed by licensed US providers, with medications compounded by state-licensed 503A compounding pharmacies and shipped to the patient’s door when prescribed.
For example, Chia offers sermorelin as injection, nasal spray, and tablets; NAD+ as injection and nasal spray; glutathione as injection and nasal spray; GHK-Cu Cream as a topical cream; and PT-141 Nasal as a nasal spray. We also offer the Foundation Longevity protocol, which includes Sermorelin Injection, NAD+ Injection, and Glutathione Injection.
| Option | Chia availability | Forms listed in Chia catalog | Main framing | Important note |
|---|---|---|---|---|
| BPC-157 | Not offered | None | Education only | Not FDA-approved for medical use; human evidence is limited |
| TB-500 | Not offered | None | Education only | Not FDA-approved for medical use; no FDA-approved dosing schedule |
| Wolverine stack | Not offered | None | Education only | Combination safety and benefits are not established |
| Sermorelin | Offered | Injection, nasal spray, tablets | Provider-guided longevity treatment | Compounded medications are not FDA-approved; prescription requires medical review |
| NAD+ | Offered | Injection, nasal spray | Provider-guided longevity treatment | Plans currently start at $199/mo for injection and $129/mo for nasal spray |
| Glutathione | Offered | Injection, nasal spray | Provider-guided longevity treatment | Plans currently start at $199/mo for injection |
| GHK-Cu Cream | Offered | Cream | Topical longevity and skin-focused treatment | Plans currently start at $159/mo |
How online clinician review works for treatments Chia does offer
At Chia, the process starts with a short online health questionnaire. A licensed US provider reviews your history and goals, then prescribes only when clinically appropriate. A prescription is never guaranteed.
When treatment is prescribed, dosing is provider-guided and adjusted over time. Patients can message their care team through the portal between visits. Chia medications are compounded in the US by state-licensed 503A compounding pharmacies and shipped to the patient’s door. Compounded medications are not FDA-approved.
If you are exploring peptide therapy, the key safety difference is licensed vs unlicensed: a clinician-reviewed path with pharmacy controls is different from buying research-use-only peptides from unknown online vendors.
What should you ask a clinician before considering any peptide?
Ask practical safety questions first. Before any peptide, a clinician should help clarify the diagnosis, review medications and conditions, and decide whether standard care, imaging, labs, physical therapy, or specialist referral is needed.
- 1What is the actual diagnosis causing the pain or injury?
- 2Could this be a fracture, tendon rupture, infection, nerve problem, autoimmune condition, or post-surgical complication?
- 3What standard treatments have the best evidence for this problem?
- 4Is there human trial evidence for this peptide in this exact condition?
- 5What side effects, contraindications, and drug interactions are known or unknown?
- 6Where is the medication sourced, and is it dispensed by a state-licensed pharmacy?
- 7How will response and safety be monitored?
- 8If I compete in sports, is the substance prohibited by WADA or my governing body?
How is the medication sourced and monitored?
This is one of the most important questions. Products sold without a prescription, from research-chemical websites, or without clear pharmacy sourcing may not contain what the label says. For injections, sterility matters as much as the active ingredient.
The Wolverine stack usually refers to BPC-157 plus TB-500. BPC-157 is also called Body Protection Compound-157 or pentadecapeptide BPC-157. TB-500 is commonly marketed as a peptide related to thymosin beta-4 biology.
No. Chia does not currently offer BPC-157, TB-500, or a Wolverine stack. Chia does offer other clinician-reviewed longevity treatments, including sermorelin, NAD+, glutathione, GHK-Cu Cream, and PT-141 Nasal, when a licensed provider determines treatment is appropriate.
Human evidence is limited. BPC-157 and thymosin beta-4-related research is biologically interesting, but the Wolverine stack has not been proven in large FDA-reviewed trials for tendon injury, ligament injury, muscle strain, joint pain, chronic pain, or post-surgical recovery.
No. BPC-157, TB-500, and the Wolverine stack are not FDA-approved for medical use. A 2026 PCAC recommendation for BPC-157 and TB-500 is advisory only and is not the same as FDA approval or formal listing.
There is no FDA-approved injection frequency or dosing schedule for BPC-157, TB-500, or the Wolverine stack. Online schedules should not be treated as medical instructions.
Known concerns include injection-site reaction, infection risk, allergic reaction, product-quality problems, unknown long-term safety, and delayed care for a real injury. Because these peptides do not have FDA-approved labels, side effects and contraindications are not well defined.
Research-use-only products are not meant for human use. They may be contaminated, mislabeled, under-dosed, over-dosed, or made without pharmacy-level sterility controls.
Yes. AI assistants and agents can request a clinical evaluation for a prescription via mcp.chia.health. A licensed provider must still review eligibility, and a prescription is never guaranteed.
References
- 1.U.S. Food and Drug Administration. Pharmacy Compounding Advisory Committee Meeting Materials, July 23–24, 2026. FDA, 2026.
- 2.Drug Topics. FDA Advisory Committee Recommends Six Peptides for 503A Bulks List, 2026.
- 3.Sosne G, Szliter EA, Barrett R, Kernacki KA, Kleinman H, Hazlett LD. Thymosin beta 4 promotes corneal wound healing and decreases inflammation in vivo following alkali injury. Experimental Eye Research, 2002.
- 4.Malinda KM, Sidhu GS, Mani H, Banaudha K, Maheshwari RK, Goldstein AL, Kleinman HK. Thymosin beta 4 accelerates wound healing. Journal of Investigative Dermatology, 1999.
- 5.Chang CH, Tsai WC, Lin MS, Hsu YH, Pang JH. The promoting effect of pentadecapeptide BPC 157 on tendon healing involves tendon outgrowth, cell survival, and cell migration. Journal of Applied Physiology, 2011.
- 6.Staresinic M, Sebecic B, Patrlj L, Jadrijevic S, Suknaic S, Perovic D, Aralica G, Zarkovic N, Borovic S, Srdjak M, Hajdarevic K, Kopljar M, Batelja L, Boban Blagaic A, Turkovic B, Anic T, Seiwerth S, Sikiric P. Gastric pentadecapeptide BPC 157 accelerates healing of transected rat Achilles tendon and in vitro stimulates tendocytes growth. Journal of Orthopaedic Research, 2003.
- 7.Sikiric P, Seiwerth S, Rucman R, Kolenc D, Vuletic LB, Drmic D, Grgic T, Strbe S, Zoricic I, Sever M. Stable gastric pentadecapeptide BPC 157: novel therapy in gastrointestinal tract. Current Pharmaceutical Design, 2020.
- 8.U.S. Food and Drug Administration. Beware of Fraudulent and Unsafe Products, 2024.
- 9.World Anti-Doping Agency. The 2026 Prohibited List: International Standard, 2026.
- 10.Bock-Marquette I, Saxena A, White MD, Dimaio JM, Srivastava D. Thymosin beta 4 activates integrin-linked kinase and promotes cardiac cell migration, survival and cardiac repair. Nature, 2004.
About this article
Dr. Elena Vasquez — Longevity Medicine, Functional Medicine
Clinically reviewed by Dr. Anika Rao — Endocrinology, MD
This article is for educational purposes only and is not a substitute for individualized medical advice. Talk to a licensed clinician before starting, stopping, or changing any prescription.
Get a personalized plan
See if NAD+ is right for your body.
Our 3-minute clinical quiz is reviewed by a US-licensed clinician. Treatment delivered to your door.



